Snowden Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.11M | Buy |
2,856
+1
| +0% | +$389 | 0.03% | 481 |
|
2025
Q1 | $1.24M | Buy |
2,855
+691
| +32% | +$301K | 0.04% | 432 |
|
2024
Q4 | $798K | Sell |
2,164
-533
| -20% | -$197K | 0.02% | 585 |
|
2024
Q3 | $1.4M | Sell |
2,697
-7
| -0.3% | -$3.64K | 0.04% | 426 |
|
2024
Q2 | $1.46M | Sell |
2,704
-92
| -3% | -$49.8K | 0.04% | 402 |
|
2024
Q1 | $1.45M | Buy |
2,796
+755
| +37% | +$391K | 0.05% | 407 |
|
2023
Q4 | $962K | Sell |
2,041
-242
| -11% | -$114K | 0.04% | 452 |
|
2023
Q3 | $994K | Sell |
2,283
-252
| -10% | -$110K | 0.04% | 421 |
|
2023
Q2 | $1.13M | Buy |
2,535
+129
| +5% | +$57.3K | 0.04% | 426 |
|
2023
Q1 | $1.11M | Sell |
2,406
-14,738
| -86% | -$6.78M | 0.04% | 434 |
|
2022
Q4 | $8.79M | Sell |
17,144
-688
| -4% | -$353K | 0.37% | 47 |
|
2022
Q3 | $8.1M | Sell |
17,832
-599
| -3% | -$272K | 0.37% | 46 |
|
2022
Q2 | $8.89M | Sell |
18,431
-471
| -2% | -$227K | 0.4% | 43 |
|
2022
Q1 | $9.29M | Buy |
18,902
+17,410
| +1,167% | +$8.55M | 0.37% | 53 |
|
2021
Q4 | $691K | Sell |
1,492
-1,723
| -54% | -$798K | 0.04% | 398 |
|
2021
Q3 | $1.2M | Buy |
3,215
+78
| +2% | +$29.1K | 0.06% | 335 |
|
2021
Q2 | $1.2M | Sell |
3,137
-668
| -18% | -$255K | 0.06% | 341 |
|
2021
Q1 | $1.37M | Buy |
3,805
+2,281
| +150% | +$819K | 0.08% | 292 |
|
2020
Q4 | $489K | Sell |
1,524
-153
| -9% | -$49.1K | 0.03% | 446 |
|
2020
Q3 | $450K | Sell |
1,677
-2
| -0.1% | -$537 | 0.04% | 407 |
|
2020
Q2 | $442K | Buy |
+1,679
| New | +$442K | 0.04% | 398 |
|
2018
Q4 | – | Sell |
-756
| Closed | -$207K | – | 472 |
|
2018
Q3 | $207K | Buy |
+756
| New | +$207K | 0.02% | 469 |
|